Skip to main content
Erschienen in: BMC Pediatrics 1/2022

Open Access 01.12.2022 | Research

Risk factors for Hirschsprung-associated enterocolitis following Soave: a retrospective study over a decade

verfasst von: Chuanping Xie, Jiayu Yan, Zhiyi Zhang, Wang Kai, Zengmeng Wang, Yajun Chen

Erschienen in: BMC Pediatrics | Ausgabe 1/2022

Abstract

Background

Hirschsprung-associated enterocolitis (HAEC), one of the most significant causes of morbidity and mortality for patients with Hirschsprung disease (HSCR), can occur before and after radical surgery. This study aims to identify the risk factors for HAEC before and after Soave. 

Methods

A retrospective study of 145 patients with HSCR treated by transanal or combination with laparoscopic or laparotomy Soave procedure between January 2011 and June 2021 was performed. Data were retrieved from the medical records. HAEC was defined as the presence of clinical signs of bowel inflammation and requiring treatment with intravenous antibiotics and rectal irrigation for at least two days in the outpatient or inpatient department. Univariate analysis and multivariate regression models were used to identify risk factors for developing pre-and postoperative HAEC.

Results

The incidence of pre-and postoperative HAEC was 24.1% and 20.7%, respectively. More than 90% of the patients with the first episode of postoperative HAEC occurred within the first year after Soave. Long-segment aganglionosis was the independent risk factor for developing preoperative HAEC ([OR] 5.8, Cl 2.4–14.2, p < 0.001), while the history of preoperative HAEC was significantly associated with developing postoperative HAEC ([OR] 4.2, Cl 1.6–10.8, p = 0.003).

Conclusions

Long-segment aganglionosis was the independent risk factor for the development of preoperative HAEC, and the history of preoperative HAEC was strongly associated with developing HAEC after Soave.

Level of Evidence

Level III
Hinweise
Chuanping Xie and Jiayu Yan contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HAEC
Hirschsprung-associated enterocolitis
HSCR
Hirschsprung disease

Introduction

Hirschsprung disease (HSCR), known as aganglionosis, is a common cause of intestinal obstruction in children. It approximately occurs in one of 5000 newborns with an overall male: female ratio of 4:1 [1]. Despite the advancement of surgical management, patients remain at risk of developing a life-threatening condition, presenting as abdominal distension, fever, diarrhea, obtunded, and ultimate sepsis [2, 3]. Bill and Chapman defined these symptoms as Hirschsprung-associated enterocolitis (HAEC) [3].
HAEC, the most significant cause of morbidity and mortality for patients with HSCR, can occur before and after the radical operation of HSCR [4, 5]. Based on recent studies, several hypotheses were involved in the pathogenesis of HAEC, including impaired mucosal immunity, immature barrier defence, dysbiosis of the intestinal microbiota, and translocation of bacteria [2, 6]. Pastor et al. primarily attempted to standardize the definition of HAEC and developed a score for HAEC with a cutoff of 10 [3]. However, it was believed that Pastor’s scoring system failed to diagnose milder HAEC [7].
Some studies have reported risk factors for preoperative and postoperative HAEC, including body weight, age of diagnosis, female sex, congenital malformation, long-segment aganglionosis, and surgical methods (Soave or Duhamel) [811]. However, the results of these studies were partially controversial. Besides, in previous studies, patients with HSCR received different surgical methods, leading to certain deviations in developing HAEC [10, 1214]. The purpose of the current study was to describe the clinical characteristics of the patients with HAEC and evaluate the risk factors for developing HAEC before and after Soave.

Materials and methods

Patient selection

Approved by the Ethics Committee of Beijing Children’s Hospital, we reviewed the medical records of consecutive patients with HSCR who underwent radical surgery at Beijing Children’s Hospital, National Center for Children’s Health, between January 2011 and June 2021. Patients who underwent radical surgery in other hospitals or patients without histopathological confirmation of HSCR were excluded. All patients underwent Soave pull-through procedure by the same surgeon team. Medical records of all patients were analyzed, including patient characteristics (gender, birth weight, gestational age, congenital malformation, age at diagnosis), surgical details, rates of HAEC, and postoperative complications (anastomotic leak). HSCR was divided into two types based on the length of the aganglionic segment: the short-segment type was defined as aganglionosis extending to the rectosigmoid, and the long-segment type as aganglionosis extending proximal to the sigmoid. The Soave pull-through procedures performed in our study were divided into two types: the operation performed by transanal endorectal pull-through (TERPT) and in combination with laparoscopic or laparotomy-assisted colonic mobilization (LERPT).
Unfortunately, it was impossible to collect all the data necessary for diagnosing HAEC by Pastor’s scoring system due to the retrospective study in nature. Therefore, the following definition of HAEC was based on clinical symptoms and treatment strategies [13], including: (a) presence of clinical signs of bowel inflammation, such as abdominal distension, diarrhea with explosive stool, fever, lethargy, a dilated loop of bowel and even sepsis, (b) that required with intravenous antibiotics and rectal irrigations at least two days in the outpatient or inpatient department.
A comparative study was performed to analyze risk factors between patients with pre-and postoperative HAEC and those without HAEC. The risk factors for preoperative HAEC were analyzed by gender, birth weight, gestational age, congenital malformation, age at diagnosis, age at surgery, weight at surgery, and length of aganglionosis. The risk factors for postoperative HAEC were analyzed by gender, birth weight, gestational age, congenital malformation, age at diagnosis, age at surgery, weight at surgery, length of aganglionosis, the presence of preoperative HAEC, surgical approach, and the presence of temporary ostomy.

Statistical analysis.

Statistical analysis was conducted using IBM SPSS Statistics for Statistics ver. 26.0 Software. Data were presented as frequency or median (interquartile range, IQR). All the statistical tests were two-sided, with a significant level of p < 0.05. On univariate analysis, Chi-squared tests or Fisher’s exact tests were applied for univariable analysis for qualitative variables and the independent sample t-test or Wilcoxon rank-sum test (Mann–Whitney) for continuous variables. Multivariable logistic regression analysis included significant variables (p < 0.05) from univariate analysis.

Results

Patient demography

From January 2011 to June 2021, 145 patients were included in our study, including 121 males and 24 females. Of these patients, 35 (35/145, 24.1%) had preoperative HAEC, and 30 (30/145, 20.7%) had postoperative HAEC. The baseline characteristics of all 145 patients are presented in Table 1. During the follow-up, more than 90% of the patients with the first episode of postoperative HAEC occurred within a year following pull-through with a median time of 24 days (Fig. 1).
Table 1
Characteristics of patients with Hirschsprung disease
Variable
N = 145
Sex
 Male
121 (83.4)
 Female
24(16.6)
Gestational age
 Preterm (< 37 weeks)
5 (3.4)
 Term (≥ 37 weeks)
140 (96.6)
Birthweight in kilograms, mean (SD)
3.31 ± 0.47
 Low birthweight (< 2500 g)
6 (4.1)
 Normal birthweight (≥ 2500 g)
139 (95.9)
Congenital malformation
11 (7.6)
Age at diagnosis in months
13.5 [6.8, 44.0]
 0–1 year of age
66 (45.5)
 > 1 year of age
79 (54.5)
Length of aganglionosisa
 Short
116 (80.0)
 Long
29 (20.0)
Age at surgery in month
20.0 [10.0, 47.5]
 0–1 year of age
46 (31.7)
 > 1 year of age
99 (68.3)
Weight at first surgery in kilogram
11.7 [9.0, 15.9]
Approach of operation technique
 Transanal only
92 (63.4)
 Laparotomy + transanal
43 (29.7)
 Laparoscopic + transanal
10 (6.9)
Temporary ostomy before radical surgery
9 (6.2)
HAEC
 Preoperative
35 (24.1)
 Postoperative
30 (20.7)
 Recurrent postoperative
11 (7.6)
Complication
 Anastomosis leak
8 (5.5)
Data are presented as median [IQR, interquartile range] and frequency (%)
Length of aganglionosisa: Long = longer than rectosigmoid, total colonic forms included (total colonic forms n = 9)

Risk factors for preoperative HAEC

Univariate analysis was performed to compare patients with preoperative HAEC (n = 35) to patients without preoperative HAEC (n = 110) (Table 2). HSCR patients with preoperative HAEC were diagnosed at a younger age (p = 0.027). Compared with short-segment aganglionosis, long-segment aganglionosis was a vital risk factor for developing preoperative HAEC ([OR] 6.3, Cl 2.6–15.2, p < 0.001). However, there was no significant association between the patients with preoperative HAEC and those without preoperative HAEC regarding sex, gestational age, weight at birth, age at radical surgery, and weight at radical surgery. On multivariable logistic regression analysis, only the length of aganglionosis was significantly associated with preoperative HAEC ([OR] 5.8, Cl 2.4–14.2, p < 0.001) adjusted by the age of diagnosing HSCR, (Table 3).
Table 2
Comparison of HSCR patients with or without preoperative HAEC
Factors
Preoperative HAEC (n = 35)
Without preoperative HAEC (n = 110)
P-value
OR
Male sex
  
0.440
1.7 [0.5, 5.4]
 Male
31 (88.6)
90 (81.8)
 Female
4 (11.4)
20 (18.2)
Gestational age
 Preterm (< 37 weeks)
2 (5.7)
3 (2.7)
0.594
2.1 [0.3, 13.5]
 Term (≥ 37 weeks)
33 (94.3)
107 (97.3)
Age at diagnosis (months)
10.5 [0, 24.8]
18.0 [7.0, 47.8]
0.027
 
Age at diagnosis
 0–1 year of age
21 (60.0)
45 (40.9)
0.054
2.2 [1.0, 4.7]
 > 1 year of age
14 (40.0)
65 (59.1)
Age at radical surgery (months)
18.5 [10.0, 37.3]
23.5 [10.0, 50.8]
0.329
 
Age at radical surgery
 0–1 year of age
13 (37.1)
33 (30.0)
0.532
1.4 [0.6, 3.1]
 > 1 year of age
22 (62.9)
77 (70.0)
Weight at birth (kg)
3.42 ± 0.45
3.27 ± 0.47
0.537
 
Weight at radical surgery (kg)
10 [8.0, 10.3]
12 [9.0, 16.0]
0.093
 
Congenital malformations
 Yes
4 (11.4)
7 (6.4)
0.462
1.9 [0.5, 6.9]
 No
31 (88.6)
103 (93.6)
Length of aganglionosisa
 Short
19 (54.3)
97 (88.2)
 < 0.001
6.3 [2.6, 15.2]
 Long
16 (45.7)
13 (11.8)
Data are presented as frequency (%) for qualitative variables and median [IQR] for continuous variables
Length of aganglionosisa: Long = longer than rectosigmoid, total colonic forms included (total colonic forms n = 9)
Table 3
Factors predicting preoperative HAEC in multivariate model
Risk factors
Odds ratio
Confidence interval
p-value
Age at diagnosis
1.0
1.0–1.02
0.295
length of aganglionosis
5.8
2.4–14.2
 < 0.001

Risk factors for postoperative HAEC

Table 4 shows the risk factors between patients with postoperative HAEC (n = 30) and patients without postoperative HAEC (n = 115). Based on univariate analysis, the length of aganglionosis ([OR] 3.1, Cl 1.3–7.6, p = 0.019), the history of preoperative HAEC ([OR] 4.8, Cl 2.0–11.3, p < 0.001) and surgical approach ([OR] 2.8, Cl 1.2–6.3, p = 0.013) were significantly associated with developing postoperative HAEC. No significant association was found between patients who had postoperative HAEC and those who did not, in terms of sex, gestational age, congenital malformation, birth weight, age at diagnosis, age at radical surgery, weight at radical surgery, and presence of a temporary ostomy. However, only the history of preoperative HAEC was the independent factor for developing postoperative HAEC adjusted by the length of aganglionosis and surgical approach on multivariable logistic regression analysis (Table 5).
Table 4
Comparison of HSCR patients with or without postoperative HAEC
Factors
Postoperative HAEC (n = 30)
Without postoperative HAEC (n = 115)
P-value
OR [95% Cl]
Male sex
 Male
24 (80.0)
97 (84.3)
0.585
0.7 [0.3, 2.1]
 Female
6 (20.0)
18 (15.7)
Gestational age
 Preterm (< 37 weeks)
1 (3.3)
4 (3.5)
 > 0.999
1.0 [0.1, 8.9]
 Term (≥ 37 weeks)
29 (96.7)
111 (96.5)
Age at diagnosis (months)
12 [1.0, 38.0]
15 [7.0, 45.5]
0.503
 
Age at radical surgery (months)
25 [8.3, 38.8]
19 [10.0, 48.0]
0.736
 
Weight at birth (kg)
3.4 [3.0, 3.6]
3.3 [3.0, 3.6]
0.392
 
Weight at radical surgery (kg)
12.5 [8.3, 38.8]
19 [10.0, 48.0]
0.842
 
Congenital malformation
 Yes
3 (10.0)
8 (7.0)
0.698
1.5 [0.4, 6.0]
 No
27 (90.0)
107 (93.0)
Length of aganglionosisa
 Short
19 (63.3)
97 (84.3)
0.019
3.1 [1.3, 7.6]
 Long
11 (36.7)
18 (15.7)
Preoperative HAEC
 Yes
15 (50.0)
20 (17.4)
 < 0.001
4.8 [2.0, 11.3]
 No
15 (50.0)
95 (82.6)
Surgical approach
 TERPT
13 (43.3)
79 (68.7)
0.013
2.8 [1.2, 6.3]
 LERPT
17 (56.7)
37 (32.2)
Temporary ostomy
 Yes
3 (10.0)
6 (5.2)
0.393
2.0 [0.5, 8.6]
 No
27 (90.0)
109 (94.8)
Data are presented as frequency (%) for qualitative variables and median [IQR] for continuous variables
Length of aganglionosisa: Long = longer than rectosigmoid, total colonic forms included (total colonic forms n = 9)
Table 5
Risk factors for developing recurrent postoperative HAEC
Risk factors
Odds ratio
Confidence interval
P-value
Length of aganglionosis
1.1
0.3–4.0
0.920
Surgical approaches
2.3
0.8–6.5
0.132
History of preoperative HAEC
4.2
1.6–10.8
0.003

Discussion

There have been several studies on the risk factors of pre-and postoperative HAEC [8, 10, 1215]. However, few studies have systematically analyzed the risk factors for HAEC before and after Soave, which might be related to fewer cases in other centers. Therefore, we performed one of the largest single-center retrospective studies to identify the risk factors for HAEC before and after Soave. HAEC can rapidly progress to septicemia, resulting in mortality in patients with HSCR [8, 16]. The incidence of pre-and postoperative HAEC ranged widely, from 6 to 50% and 2% to 35%, which might be related to heterogeneity in case definitions and differences in clinical characteristics of the cohorts [13, 17]. In our center, the age for radical surgery was significantly older than in most previous reports [8, 12]. Nearly 70% of HSCR patients underwent radical surgery after 1 year because they usually suffered from less severe symptoms, which could be improved through conservative treatments. Most of them would not be transferred to hospitals for radical surgery until presenting more severe symptoms. It could also explain why the incidence of preoperative HAEC (24.1%) was relatively higher than most previous reports [8, 12, 15].
Our study’s univariate analysis revealed that the earlier age at diagnosing HSCR and long-segment aganglionosis segment were associated with developing preoperative HAEC. However, regression analysis identified that only the long-segment aganglionosis segment was the independent risk factor for the development of preoperative HAEC. It could be explained that patients with long-segment aganglionosis tended to have more severe symptoms at a younger age, leading to an earlier age of diagnosing HSCR [18, 19]. The mechanism of an increased risk factor for developing HAEC was as follows: first, the longer aganglionosis tends to produce the proximal bowel obstruction and generate more significant intraluminal pressure, leading to a higher vulnerability to bacterial stasis and intestinal dysmotility; second, it also involves the impairment of the bowel immune system, resulting in pathogenic bacteria overgrowth and possible bacteria translocation [8, 10]. Previous studies suggested that congenital malformations and lower birth weight were associated with preoperative HAEC [8, 15]. In contrast to these studies, our study did not support these results, which might be related to the absence of severe congenital malformations (such as congenital cardiac or neurologic anomalies and chromosome abnormalities) and the low frequency of premature infants.
In our study, the incidence of postoperative HAEC was 20.7%, and more than 90% of the patients with the first episode of postoperative HAEC occurred within a year following the pull-through [12, 20]. Univariate analysis revealed that the length of aganglionosis, surgical approaches, and the history of preoperative enterocolitis were significantly associated with developing postoperative HAEC. However, multivariable logistic regression analysis established that only the history of preoperative HAEC was strongly associated with the increased risk of postoperative HAEC since patients with long-segment aganglionosis tended to present more severe symptoms before radical surgery [2, 10, 20]. A hypothesis proposed that patients with preoperative HAEC episodes could change resultant short-chain fatty, alter the composition of bacteria, and reduce the diversity of fungi, leading to dysbiosis in the gut microbial ecosystem, even after radical surgery [2123]. The changes in intestinal microbiota made patients susceptible to the development of further episodes of HAEC [10, 22]. Previous studies also suggested that a higher pathological HAEC score of the resected colon in HSCR patients could increase the risk of developing further episodes of enterocolitis, and the severity of enterocolitis in the transitional zone was the most significant factor [24, 25]. To reduce the incidence of postoperative HAEC, it was recommended that radical surgery be performed at an early age before the presence of severe symptoms [13]. Earlier radical surgery for HSCR patients could improve intestinal microbiota and reduce the incidence of preoperative enterocolitis [13, 26]. For patients with preoperative HAEC, conservation treatment should be given first, such as antibiotics and rectal irrigations. However, a temporary enterostomy might be needed for the patients who failed to improve with non-operative management, and radical surgery should be performed until the patients’ conditions are stable [2]. Some previous studies proposed that long-segment aganglionosis could increase the risk of developing HAEC after radical surgery [10, 19], but our study did not demonstrate it on multivariable logistic regression. The possible reasons might be as follow. On the one hand, we were prone to remove all the lesion bowel (including spasm segment, transitional and proximal dilated zones) to make the proximal pull-through bowel normal in terms of pathology and morphology, effectively reducing residual neuronal incidence dysplasia in the proximal bowel [27]. On the other hand, our patients began routine anal dilatation two weeks after radical surgery, which could reduce the frequency of anastomotic stricture and assist patients in developing regular bowel movements by stimulating the anus [16, 28, 29].
In our center, there were 8 patients with recurrent episodes of HAEC after Soave. Four patients had an uneventful recovery after the treatment of bowel rest, rectal irrigations, and broad-spectrum antibiotics, and four patients underwent a repeated pull-through due to residual intestinal neuronal dysplasia. It is critical to evaluate for an anatomic/pathological or functional obstruction and carefully examine patients with recurrent HAEC after Soave, such as barium enema, anorectal pressure measurement, or rectal biopsy [2, 20]. Although we tend to remove all the lesion bowel, some patients suffered recurrent enterocolitis after Soave due to residual intestinal neuronal dysplasia, and repeated pull-through was required. Moreover, for patients with obstructive symptoms due to non-relaxation of the internal anal sphincter, it has been proposed that intrasphincteric botulinum toxin injection could alleviate obstructive defecation problems following pull-through with mild adverse effects [2, 30, 31].
The study has some limitations. One of the limitations of our study is the lack of a standardized definition for diagnosing HAEC. Although Pastor et al. attempted to standardize the definition of HAEC and developed a scoring system based on Delphic analysis, collecting the data necessary for Pastor’s scoring system was challenging because part of our cohort had been treated with antibiotics or rectal irrigation before validating the scores. Besides, our case definition might be strict for diagnosing HAEC. Some patients with milder HAEC treated with oral antibiotics at home without hospitalization might be excluded from our study, leading to a potential selection bias. Last but not least, Our study is retrospective and single-center, which could also result in a particular deviation.

Conclusions

In conclusion, long-segment aganglionosis was the independent risk factor for developing preoperative HAEC, while the history of preoperative HAEC was strongly associated with developing HAEC after Soave.

Acknowledgements

CPX thanks his parents for always accompanying him to grow up.

Financial support statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Disclosure

The authors declare that they have no conflict of interest.

Declarations

This study adheres to the ethical principles of the Declaration of Helsinki. It was approved by the Ethics Committee of Beijing Children’s Hospital (2021-E-132-R). Written informed consent was obtained from the patient’s parents.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2007;45(1):1–14.CrossRefPubMed Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2007;45(1):1–14.CrossRefPubMed
2.
Zurück zum Zitat Gosain A, Frykman PK, Cowles RA, et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517–21.CrossRefPubMedPubMedCentral Gosain A, Frykman PK, Cowles RA, et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517–21.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Pastor AC, Osman F, Teitelbaum DH, et al. development of a standardized definition for Hirschsprung’s-associated enterocolitis: a Delphi analysis. J Pediatr Surg. 2009;44(1):251–6.CrossRefPubMed Pastor AC, Osman F, Teitelbaum DH, et al. development of a standardized definition for Hirschsprung’s-associated enterocolitis: a Delphi analysis. J Pediatr Surg. 2009;44(1):251–6.CrossRefPubMed
4.
Zurück zum Zitat Ruttenstock E, Puri P. Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprung’s disease. Pediatr Surg Int. 2010;26(11):1101–5.CrossRefPubMed Ruttenstock E, Puri P. Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprung’s disease. Pediatr Surg Int. 2010;26(11):1101–5.CrossRefPubMed
5.
Zurück zum Zitat Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung’s disease. Pediatr Surg Int. 2006;22(4):316–8.CrossRefPubMed Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung’s disease. Pediatr Surg Int. 2006;22(4):316–8.CrossRefPubMed
6.
Zurück zum Zitat Gosain A, Brinkman AS. Hirschsprung’s associated enterocolitis. Cur Opin Pediatr. 2015;27(3):364–9.CrossRef Gosain A, Brinkman AS. Hirschsprung’s associated enterocolitis. Cur Opin Pediatr. 2015;27(3):364–9.CrossRef
7.
Zurück zum Zitat Frykman PK, Kim S, Wester T, et al. Critical evaluation of the Hirschsprung-associated enterocolitis (HAEC) score: A multicenter study of 116 children with Hirschsprung disease. J Pediatr Surg. 2018;53(4):708–17.CrossRefPubMed Frykman PK, Kim S, Wester T, et al. Critical evaluation of the Hirschsprung-associated enterocolitis (HAEC) score: A multicenter study of 116 children with Hirschsprung disease. J Pediatr Surg. 2018;53(4):708–17.CrossRefPubMed
8.
Zurück zum Zitat Le-Nguyen A, Righini-Grunder F, Piche N, et al. Factors influencing the incidence of Hirschsprung associated enterocolitis (HAEC). J Pediatr Surg. 2019;54(5):959–63.CrossRefPubMed Le-Nguyen A, Righini-Grunder F, Piche N, et al. Factors influencing the incidence of Hirschsprung associated enterocolitis (HAEC). J Pediatr Surg. 2019;54(5):959–63.CrossRefPubMed
9.
Zurück zum Zitat Prato AP, Arnoldi R, Sgro A, et al. Hirschsprung disease and Down syndrome: From the reappraisal of risk factors to the impact of surgery. J Pediatr Surg. 2019;54(9):1838–42.CrossRef Prato AP, Arnoldi R, Sgro A, et al. Hirschsprung disease and Down syndrome: From the reappraisal of risk factors to the impact of surgery. J Pediatr Surg. 2019;54(9):1838–42.CrossRef
10.
Zurück zum Zitat Parahita IG, Makhmudi A. Gunadi, Comparison of Hirschsprung-associated enterocolitis following Soave and Duhamel procedures. J Pediatr Surg. 2018;53(7):1351–4.CrossRefPubMed Parahita IG, Makhmudi A. Gunadi, Comparison of Hirschsprung-associated enterocolitis following Soave and Duhamel procedures. J Pediatr Surg. 2018;53(7):1351–4.CrossRefPubMed
12.
Zurück zum Zitat Roorda D, Oosterlaan J, Heurn E, et al. Risk factors for enterocolitis in patients with Hirschsprung disease: A retrospective observational study. J Pediatr Surg. 2021;56(10):1791–8.CrossRefPubMed Roorda D, Oosterlaan J, Heurn E, et al. Risk factors for enterocolitis in patients with Hirschsprung disease: A retrospective observational study. J Pediatr Surg. 2021;56(10):1791–8.CrossRefPubMed
13.
Zurück zum Zitat Sakurai T, Tanaka H, Endo N. Predictive factors for the development of postoperative Hirschsprung-associated enterocolitis in children operated during infancy. Pediatr Surg Int. 2021;37(2):275–80.CrossRefPubMed Sakurai T, Tanaka H, Endo N. Predictive factors for the development of postoperative Hirschsprung-associated enterocolitis in children operated during infancy. Pediatr Surg Int. 2021;37(2):275–80.CrossRefPubMed
14.
Zurück zum Zitat Gunadi, Sukarelawanto AVR, Ritana A, et al. Postoperative enterocolitis assessment using two different cutoff values in the HAEC score in Hirschsprung patients undergoing Duhamel and Soave pull-through. BMC Pediatr 2020;20(1):457. Gunadi, Sukarelawanto AVR, Ritana A, et al. Postoperative enterocolitis assessment using two different cutoff values in the HAEC score in Hirschsprung patients undergoing Duhamel and Soave pull-through. BMC Pediatr 2020;20(1):457.
15.
Zurück zum Zitat Yulianda D, Sati AI, Makhmudi A, et al. Risk factors of preoperative Hirschsprung-associated enterocolitis. BMC pro. 2019;13(11):18.CrossRef Yulianda D, Sati AI, Makhmudi A, et al. Risk factors of preoperative Hirschsprung-associated enterocolitis. BMC pro. 2019;13(11):18.CrossRef
16.
Zurück zum Zitat Lin Z, Liu Y, Wu D, et al. Outcomes of preoperative anal dilatation for Hirschsprung disease. J Pediatr Surg. 2021;56(3):483–6.CrossRefPubMed Lin Z, Liu Y, Wu D, et al. Outcomes of preoperative anal dilatation for Hirschsprung disease. J Pediatr Surg. 2021;56(3):483–6.CrossRefPubMed
17.
Zurück zum Zitat Austin KM. The pathogenesis of Hirschsprung’s disease-associated enterocolitis. Semin Pediatr Surg. 2012;21(4):319–27.CrossRefPubMed Austin KM. The pathogenesis of Hirschsprung’s disease-associated enterocolitis. Semin Pediatr Surg. 2012;21(4):319–27.CrossRefPubMed
18.
Zurück zum Zitat Haricharan RN, Seo JM, Kelly DR, et al. Older age at diagnosis of Hirschsprung disease decreases risk of postoperative enterocolitis, but resection of additional ganglionated bowel does not. J Pediatr Surg. 2008;43(6):1115–23.CrossRefPubMed Haricharan RN, Seo JM, Kelly DR, et al. Older age at diagnosis of Hirschsprung disease decreases risk of postoperative enterocolitis, but resection of additional ganglionated bowel does not. J Pediatr Surg. 2008;43(6):1115–23.CrossRefPubMed
19.
Zurück zum Zitat Lee CC, Lien R, Chiang MC, et al. Clinical Impacts of Delayed Diagnosis of Hirschsprung’s Disease in Newborn Infants. Pediatr Neonatol. 2012;53(2):133–7.CrossRefPubMed Lee CC, Lien R, Chiang MC, et al. Clinical Impacts of Delayed Diagnosis of Hirschsprung’s Disease in Newborn Infants. Pediatr Neonatol. 2012;53(2):133–7.CrossRefPubMed
20.
Zurück zum Zitat Pruitt LCC, Skarda DE, Rollins MD, et al. Hirschsprung-associated enterocolitis in children treated at US children’s hospitals. J Pediatr Surg. 2020;55(3):535–40.CrossRefPubMed Pruitt LCC, Skarda DE, Rollins MD, et al. Hirschsprung-associated enterocolitis in children treated at US children’s hospitals. J Pediatr Surg. 2020;55(3):535–40.CrossRefPubMed
21.
Zurück zum Zitat Demehri FR, Frykman PK, Cheng Z, et al. Altered fecal short chain fatty acid composition in children with a history of Hirschsprung-associated enterocolitis. J Pediatr Surg. 2016;51(1):81–6.CrossRefPubMed Demehri FR, Frykman PK, Cheng Z, et al. Altered fecal short chain fatty acid composition in children with a history of Hirschsprung-associated enterocolitis. J Pediatr Surg. 2016;51(1):81–6.CrossRefPubMed
22.
Zurück zum Zitat Frykman PK, Nordenskjold A, Kawaguchi A, et al. Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study. PLoS One. 2015;10(4):e0124172.CrossRefPubMedPubMedCentral Frykman PK, Nordenskjold A, Kawaguchi A, et al. Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study. PLoS One. 2015;10(4):e0124172.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Shen D, Shi CR, Chen JJ, et al. Detection of intestinal bifidobacteria and lactobacilli in patients with Hirschsprung’s disease associated enterocolitis. World J Pediatr. 2009;5(3):201–5.CrossRefPubMed Shen D, Shi CR, Chen JJ, et al. Detection of intestinal bifidobacteria and lactobacilli in patients with Hirschsprung’s disease associated enterocolitis. World J Pediatr. 2009;5(3):201–5.CrossRefPubMed
24.
Zurück zum Zitat Cheng S, Wang J, Pan W, et al. Pathologically assessed grade of Hirschsprung-associated enterocolitis in resected colon in children with Hirschsprung’s disease predicts postoperative bowel function. J Pediatr Surg. 2017;52(11):1776–81.CrossRefPubMed Cheng S, Wang J, Pan W, et al. Pathologically assessed grade of Hirschsprung-associated enterocolitis in resected colon in children with Hirschsprung’s disease predicts postoperative bowel function. J Pediatr Surg. 2017;52(11):1776–81.CrossRefPubMed
25.
Zurück zum Zitat Farrugia MK, Alexander N, Clarke S, et al. Does transitional zone pull-through in Hirschsprung’s disease imply a poor prognosis? J Pediatr Surg. 2003;38(12):1766–9.CrossRefPubMed Farrugia MK, Alexander N, Clarke S, et al. Does transitional zone pull-through in Hirschsprung’s disease imply a poor prognosis? J Pediatr Surg. 2003;38(12):1766–9.CrossRefPubMed
26.
Zurück zum Zitat Cheng Z, Zhao L, Dhall D, et al. Bacterial Microbiome Dynamics in Post Pull-Through Hirschsprung-Associated Enterocolitis (HAEC): An Experimental Study Employing the Endothelin Receptor B-Null Mouse Model. Front Surg. 2018;5:30.CrossRefPubMedPubMedCentral Cheng Z, Zhao L, Dhall D, et al. Bacterial Microbiome Dynamics in Post Pull-Through Hirschsprung-Associated Enterocolitis (HAEC): An Experimental Study Employing the Endothelin Receptor B-Null Mouse Model. Front Surg. 2018;5:30.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Estevão-Costa J, Fragoso AC, Campos M, et al. An approach to minimize postoperative enterocolitis in Hirschsprung’s disease. J Pediatr Surg. 2006;41(10):1704–7.CrossRefPubMed Estevão-Costa J, Fragoso AC, Campos M, et al. An approach to minimize postoperative enterocolitis in Hirschsprung’s disease. J Pediatr Surg. 2006;41(10):1704–7.CrossRefPubMed
28.
Zurück zum Zitat Keshtgar AS, Ward HC, Clayden GS, et al. Role of anal dilatation in treatment of idiopathic constipation in children: long-term follow-up of a double-blind randomized controlled study. Pediatr Surg Int. 2005;21(2):100–5.CrossRefPubMed Keshtgar AS, Ward HC, Clayden GS, et al. Role of anal dilatation in treatment of idiopathic constipation in children: long-term follow-up of a double-blind randomized controlled study. Pediatr Surg Int. 2005;21(2):100–5.CrossRefPubMed
29.
Zurück zum Zitat Jumbi T, Kuria K, Osawa F, et al. The effectiveness of digital anal dilatation in preventing anal strictures after anorectal malformation repair. J Pediatr Surg. 2019;54(10):2178–81.CrossRefPubMed Jumbi T, Kuria K, Osawa F, et al. The effectiveness of digital anal dilatation in preventing anal strictures after anorectal malformation repair. J Pediatr Surg. 2019;54(10):2178–81.CrossRefPubMed
30.
Zurück zum Zitat Roorda D, Oosterlaan J, van Heurn E, et al. Intrasphincteric botulinum toxin injections for postoperative obstructive defecation problems in hirschsprung disease: A retrospective observational study. J Pediatr Surg. 2021;56(8):1342–8.CrossRefPubMed Roorda D, Oosterlaan J, van Heurn E, et al. Intrasphincteric botulinum toxin injections for postoperative obstructive defecation problems in hirschsprung disease: A retrospective observational study. J Pediatr Surg. 2021;56(8):1342–8.CrossRefPubMed
31.
Zurück zum Zitat Roorda D, Abeln ZA, Oosterlaan J, et al. Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis. World J Gastroenterol. 2019;25(25):3268–80.CrossRefPubMedPubMedCentral Roorda D, Abeln ZA, Oosterlaan J, et al. Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis. World J Gastroenterol. 2019;25(25):3268–80.CrossRefPubMedPubMedCentral
Metadaten
Titel
Risk factors for Hirschsprung-associated enterocolitis following Soave: a retrospective study over a decade
verfasst von
Chuanping Xie
Jiayu Yan
Zhiyi Zhang
Wang Kai
Zengmeng Wang
Yajun Chen
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Pediatrics / Ausgabe 1/2022
Elektronische ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-022-03692-6

Weitere Artikel der Ausgabe 1/2022

BMC Pediatrics 1/2022 Zur Ausgabe

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.